PBH, CRWE, THLD - CRWESelect.com Stock News! Prestige Brand Holdings Inc., Threshold Pharmaceuticals Inc., Crown Equity Holdings Inc. (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) February 21, 2012 -- To view video, and read the full article visit URL http://crweselect.com/28707/stock-alerts/pbh-crwe-thld-crweselectcom-stock-news-prestige-brand-holdings-inc-threshold-pharmaceuticals-inc-crown-equity-holdings-inc-video-included-inside/

Prestige Brand Holdings, Inc. (NYSE: PBH)

Genomma Lab Internacional, S.A.B. de C.V. announced that it has submitted a non-binding proposal to acquire all of the outstanding shares of Prestige Brands Holdings, Inc. (PBH) common stock for $16.60 dollars per share in cash. The transaction is valued at approximately $834 million dollars, not including Prestige's net debt.

PBH , together with its subsidiaries, engages in marketing, selling, and distributing over-the-counter healthcare and household cleaning products primarily in North America.

For more information about PBH please visit http://www.prestigebrandsinc.com

****

Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)

Threshold Pharmaceuticals, Inc. (THLD) announced that its 214 patient randomized controlled Phase 2b clinical trial evaluating the efficacy and safety of two doses of the investigational agent TH-302 in combination with gemcitabine compared to gemcitabine alone in patients with first-line advanced pancreatic cancer achieved its primary endpoint, with a 63% improvement in progression free survival and a safety profile consistent with previous studies.

THLD is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs.

For more information about THLD please visit http://www.thresholdpharm.com

****

Crown Equity Holdings Inc. (CRWE.OB)

Crown Equity Holdings Inc. (CRWE) previously reported that its subsidiary Crown Tele Services Inc. has entered into a letter of intent with BBN Solutions. In addition, Crown Equity Holdings Inc. previously announced that its subsidiary Crown Tele Services Inc. has entered into a letter of intent with MVOX AG. Crown Tele Services, a subsidiary of Crown Equity Holdings Inc. is a leading provider of affordable, world class VoIP communications solutions, with a network utilizing fast fiber optic channels throughout the world, exploiting the power of IP with unified communication tools that anyone can use.

Also, Crown Equity Holdings Inc. recently reported that it has launched two new online service companies. CRWE Direct and CRWE Real Estate. CRWE Direct is an online business-to-business marketplace for manufacturers and small to large businesses to purchase various types of merchandise. Manufacturers may start downloading their product immediately, free of charge during the next six months. Thereafter, there will be various annual fees. The listing process and image loading for both sites are user-friendly. Crown Equity Holdings Inc. has launched CRWE Real Estate to provide a global portal for property listings at a fee of only $1 a day.

CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Crown Equity Holdings advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

For more information about CRWE please visit http://www.crownequityholdings.com

To read the full article visit URL http://crweselect.com/28707/stock-alerts/pbh-crwe-thld-crweselectcom-stock-news-prestige-brand-holdings-inc-threshold-pharmaceuticals-inc-crown-equity-holdings-inc-video-included-inside/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

PBHcrweselect0221
CRWEcrweselect0221
THLDcrweselect0221

Crown Equity Holdings     Crown Tele Services     CRWE Direct     CRWE Real Estate     Prestige Brand Holdings     select     Threshold Pharmaceuticals